CEBPA and viral infectious disease: In our previous study, C/EBP-α protein level was increased in activated HSCs by non-physiologic approaches, such as plasmid transfection and viral infection; and the exogenous expressed C/EBP-α has been shown to inhibit HSC activation and displayed a repressing effect on hepatic fibrosis6–8.